PLAINSBORO, N.J., April 11, 2018 -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release first quarter 2018 financial results on Wednesday, April 25, 2018, prior to market open. In conjunction with the earnings release, Integra will host a conference call at 8:30 a.m. ET.
Peter J. Arduini, president and chief executive officer, and Glenn Coleman, chief financial officer and corporate vice-president of International, will review first quarter 2018 results during the call.
The live call is accessible by dialing (323) 794-2093 and using the passcode 5958152. A simultaneous webcast of the call will be available via the Company’s website at www.integralife.com.
A webcast replay of the call can be accessed through the Investor Relations homepage of Integra's website at www.integralife.com. A replay of the call will be available through April 30, 2018 by dialing (719) 457-0820 and using the passcode 5958152.
About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, Certas™, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™. For the latest news and information about Integra and its brands, please visit www.integralife.com.
Investor Relations:
Michael Beaulieu
Director, Investor Relations
(609) 750-2827
[email protected]
Media Contact:
Laurene Isip
Senior Director, Global Corporate Communications
(609) 750-7984
[email protected]


More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
How Marco Pharma International Preserves German Homeopathic Traditions in America
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 



